Xeris Biopharma Holdings, Inc.
XERS
19 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 12 9:20 PM | BARBARA-JEAN A BORMANN-KENNEDY | Proposed Sale | 15,000 | $7.01 | $105.2K | — | View → |
| Nov 13, 2025 | Nov 13 9:25 PM | JOHN SHANNON | Proposed Sale | 48,149 | $7.59 | $365.5K | — | View → |
| Nov 11, 2025 | Nov 12 12:02 PM | BETH HECHT | Proposed Sale | 66,668 | $7.72 | $514.7K | — | View → |
| Sep 11, 2025 | Sep 11 8:24 PM | MARLA PERSKY | Proposed Sale | 15,500 | $7.81 | $121.1K | — | View → |
| Aug 28, 2025 | Aug 28 8:09 PM | JEFFREY SHERMAN | Proposed Sale | 42,232 | $7.92 | $334.5K | — | View → |
| Aug 13, 2025 | Aug 13 8:08 PM | JOHN H JOHNSON | Proposed Sale | 107,500 | $7.32 | $786.5K | — | View → |
| Aug 12, 2025 | Aug 12 8:23 PM | DAWN HALKUFF | Proposed Sale | 42,500 | $7.28 | $309.2K | — | View → |
| May 9, 2025 | May 9 9:28 PM | Fairley Ricki Louise | Proposed Sale | 56,667 | $4.90 | $277.7K | — | View → |
| Mar 20, 2025 | Mar 20 9:26 PM | Hecht Beth | Proposed Sale | 40,000 | $5.14 | $205.6K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 5 10:39 PM | Garheng KongDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 10:29 PM | Marla PerskyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 10:18 PM | Dawn HalkuffDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 10:18 PM | Barbara-Jean Anne Bormann-KennedyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 10:17 PM | John JohnsonDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 10:16 PM | James Aloysius BradyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Mar 12, 2026 | Mar 16 10:11 PM | Kevin MccullochPresident and Chief Operating Officer | Option Exercise | 48,898 | $4.09 | 79,996(D) | View → |
| Mar 5, 2026 | Mar 6 12:18 AM | Steven PieperChief Financial Officer | Option Exercise | 41,927 | $5.93 | 0(D) | View → |
| Jan 30, 2026 | Feb 2 11:13 PM | John Patrick Shannon JrDirector, Chief Executive Officer and Director | Grant/Award | 639,639 | $7.36 | 639,639(D) | View → |
| Jan 30, 2026 | Feb 2 11:12 PM | Kevin MccullochPresident and Chief Operating Officer | Grant/Award | 225,225 | $7.36 | 225,225(D) | View → |
| Jan 30, 2026 | Feb 2 11:12 PM | Steven PieperChief Financial Officer | Grant/Award | 207,207 | $7.36 | 207,207(D) | View → |
| Jan 30, 2026 | Feb 2 11:11 PM | Anh Tu NguyenChief Medical Officer | Grant/Award | 162,162 | $7.36 | 162,162(D) | View → |
| Jan 30, 2026 | Feb 2 11:11 PM | Beth HechtChief Legal Officer and Corporate Secretary | Grant/Award | 162,162 | $7.36 | 162,162(D) | View → |